Frontiers Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID 19 vaccine Read "Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups" at NAP.edu Randomised controlled trial participants: Diversity data report NIHR Evidence based selection of the starting dose in first in human clinical trials using humanized mouse models Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high risk HER2 positive early breast cancer (DESTINY Breast11): a randomised, open label, multicentre, phase III trial Annals of Oncology